17 Jan 2022
COVID-19: Pfizer CEO sees a Return to ‘Normal Life’ in the Spring
The Index Today
The Antiviral COVID-19 drugs from Pfizer are seen as the next step in the fight against the virus.
Albert Bourla, the CEO of Pfizer, said in an interview published late Sunday that he believes there will be a huge chance of "return to normal life" sometime in the spring after over two years of dealing with the COVID-19 pandemic.
According to the Financial Times, Bourla made the comments to Le Figaro, the French newspaper. Bourla credits the high number of testing facilities, vaccinations and emerging treatments as key factors at play for the world's eventual emergence from the COVID-19 epidemic, which has already killed 850,000 people just in the U.S. alone.
Reports also said that the antiviral COVID-19 drugs are seen as the next step in the fight against the virus. The vaccines have been credited with helping to prevent deaths during the recent wave of infections, but critics say they have done little to slow the disease’s spread due to the transmissibility of the omicron variant.
©Photo: AP Photo/Giannis Papanikos, File